Q: This morning, Opsens received a takeover offer from Haemonetics. Do you think there's any potential for other bidders to offer more than the current $2.90 cash offer?

Many thanks.

Q: The market seems to like the news but I would appreciate your views on their just released Q1 results. I realize that they still came in at a loss but that was solely attributable to an increase in operating costs (specifically R&D and a ramp up of its US sales force in advance of the release of SavvyWire). I remain surprised that we're still trading below their recent financing level. Thanks as always.

Q: 1] Opsens Inc XTSE: OPS $2.23 CAD▲ +0.05 (+2.29%) today

2] OpSens Inc.

Short Description: Treasury Offering of Common Shares

Price: $1.90 CND per share.

Settlement: December 22, 2022.

Are 1 & 2 the same?

What does it do exactly? How do I buy it at $1.90? Is it worth buying?

Thank you.